Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $247.9 million.

  • Metagenomi's Liabilities and Shareholders Equity fell 3081.11% to $247.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 2504.51%. This contributed to the annual value of $324.6 million for FY2024, which is 1103.03% down from last year.
  • Per Metagenomi's latest filing, its Liabilities and Shareholders Equity stood at $247.9 million for Q3 2025, which was down 3081.11% from $272.3 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Liabilities and Shareholders Equity registered a high of $415.4 million during Q1 2024, and its lowest value of $247.9 million during Q3 2025.
  • Over the past 3 years, Metagenomi's median Liabilities and Shareholders Equity value was $341.5 million (recorded in 2024), while the average stood at $333.4 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 1103.03% in 2024, then crashed by 3081.11% in 2025.
  • Over the past 3 years, Metagenomi's Liabilities and Shareholders Equity (Quarter) stood at $364.8 million in 2023, then dropped by 11.03% to $324.6 million in 2024, then dropped by 23.62% to $247.9 million in 2025.
  • Its Liabilities and Shareholders Equity was $247.9 million in Q3 2025, compared to $272.3 million in Q2 2025 and $297.9 million in Q1 2025.